Drug Profile
Osteoprotegerin - SnowBrand
Alternative Names: OCIF - SnowBrand; OPG - SnowBrand; Osteoclastogenesis Inhibiting Factor - SnowBrandLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator SnowBrand Pharmaceuticals
- Class
- Mechanism of Action Bone resorption factor inhibitors; Osteoclast inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bone disorders; Postmenopausal osteoporosis
Most Recent Events
- 10 Nov 1998 Preclinical development for Bone disorders in USA (Unknown route)
- 10 Nov 1998 Preclinical development for Postmenopausal osteoporosis in USA (Unknown route)